Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1716595Generated: November 1, 2026

1-Ethyl-3-(3'-dimethylaminopropyl)carbodiimide → HCID 68513435, compound

https://huagongshe.com/reaction/1716595

Reaction equation

Participants

RoleNameHCIDCharge
Reactant1-Ethyl-3-(3'-dimethylaminopropyl)carbodiimideHCID 15908—
Reactant1-HydroxybenzotriazoleHCID 75771—
ReactantDiisopropylethylamineHCID 81531—
ReactantHCID 68513351HCID 68513351—
ReactantHCID 68513390HCID 68513390—
SolventWaterHCID 962—
SolventDimethylformamideHCID 6228—
ProductHCID 68513435HCID 6851343598%

Reaction Steps

To a solution of 2-(5-methyl-1-piperidin-4-yl-1H-benzoimidazol-2-yl)-propan-2-ol hydrochloride salt (158 mg, 0.55 mmol) in DMF (5 ml) was added N,N-diisopropylethylamine (150 mg, 1.15 mmol). After stirring for 10 minutes, 5-tert-butoxycarbonylamino-indan-2-carboxylic acid (140 mg, 0.55 mmol) was added to the reaction mixture followed by EDCI (195 mg, 1.10 mmol) and HOBT (137 mg, 1.10 mmol). After stirring at rt for 4 hours, the reaction mixture was diluted with water, and the aqueous layer was extracted with ethyl acetate. The combined organic extracts were washed with saturated NaHCO3, brine, and dried over Na2SO4. The extracts were filtered and concentrated in vacuo to afford (2-{4-[2-(1-hydroxy-1-methyl-ethyl)-5-methyl-benzoimidazol-1-yl]-piperidine-1-carbonyl}-indan-5-yl)-carbamic acid tert-butyl ester (266 mg, 98%) as a white solid without further purification.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS07803816B2
Source datasetuspto-grants-2010_09
ORD IDord-408bc26b36fa45cd9e6848e98806bd94
Source noteuspto-grants-2010_09